Assessment of the relationship between vascular diseases and exposure to toxic metals

Year 2025, Volume: 7 Issue: 1, 48 - 53, 10.01.2025

Serkan Şahin , Fethi Sada Zekey , Zafer Cengiz Er , Vugar Ali Türksoy

https://doi.org/10.38053/acmj.1551420

Abstract

Aims: Understanding the factors in the etiology of vascular diseases is crucial for prevention. This study assesses the relationship between toxic metal exposure and vascular disease development.
Methods: Blood samples from 41 healthy volunteers and 48 cardiovascular disease patients were analyzed using inductively coupled plasma mass spectrometry (ICP-MS). The participants' health data were obtained from hospital records.
Results: ICP-MS results showed higher levels of As (5.97 µg/L), Cd (0.44 µg/L), Hg (0.48 µg/L), Pb (37.10 µg/L), Se (75.76 µg/L), Cu (1611.99 µg/L), Mn (14.55 µg/L), Co (0.14 µg/L), Mo (1.93 µg/L), and Ni (0.25 µg/L) in the experimental group. Conversely, Zn (557.0 µg/L), Cr (4.12 µg/L), and Sb (2.35 µg/L) levels were lower. Triglyceride (135.99 mg/dl), folate (8.77 ng/dl), and T3 (1.30 ng/dl) were higher, while HDL (44.13 mg/dl) was lower in the experimental group.
Conclusion: These findings suggest a potential relationship between higher exposure to certain toxic metals and the development of vascular diseases. The higher concentrations of toxic metals in the blood of patients with vascular diseases underline the need for further research to confirm these associations and explore potential mechanisms.

Keywords

Toxic metals, vascular diseases, ICP-MS, cardiovascular health, environmental exposure

Ethical Statement

This study received ethical approval from the Yozgat Bozok University Ethics Committee, approval number: 2017-KAEK-189_2021.08.25_01

Supporting Institution

Yozgat Bozok University Scientific Research Projects Unit

Project Number

TÇD-2021-918

References

• Qin P, Huang C, Jiang B, et al. Dietary carbohydrate quantity and quality and risk of cardiovascular disease, all-cause, cardiovascular and cancer mortality: a systematic review and meta-analysis. Clin Nutr. 2023;42(2):148-165.
• Gaidai O, Cao Y, Loginov S. Global cardiovascular diseases death rate prediction. Curr Probl Cardiol. 2023;48(5):101622.
• Çevik S, Akman M. Frequency and risk assessment of cardiovascular diseases in the world and Turkey. J Turkish Fam Physician. 2022;13(1):21-28.
• Jamison DT, Summers LH, Chang AY, et al. Global health 2050: the path to halving premature death by mid-century. Lancet. 2024; 404(10462):1561-1614.
• Gonçalves-Martins G, Gil-Sala D, Tello-Díaz C, et al. Prevalence of peripheral arterial disease and associated vascular risk factors in 65-years-old people of Northern Barcelona. J Clin Med. 2021;10(19):4467.
• Wittens C, Davies A, Bækgaard N, et al. Editor’s choice–management of chronic venous disease: clinical practice guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2015; 49(6):678-737.
• Gil-Montoya JA, de Mello ALF, Barrios R, et al. Oral health in the elderly patient and its impact on general well-being: a nonsystematic review. Clin Interv Aging. 2015;10:461-467.
• Ahmad W, Alharthy RD, Zubair M, et al. Toxic and heavy metals contamination assessment in soil and water to evaluate human health risk. Sci Rep. 2021;11(1):17006.
• Nucera S, Serra M, Caminiti R, et al. Non-essential heavy metal effects in cardiovascular diseases: an overview of systematic reviews. Front Cardiovasc Med. 2024;11:1332339.
• Pan Z, Gong T, Liang P. Heavy metal exposure and cardiovascular disease. Circ Res. 2024;134(9):1160-1178.
• Prozialeck WC, Edwards JR, Nebert DW, et al. The vascular system as a target of metal toxicity. Toxicol Sci. 2008;102(2):207-218.
• He J, Wang M, Jiang Y, et al. Chronic arsenic exposure and angiogenesis in human bronchial epithelial cells via the ROS/miR-199a-5p/HIF-1α/COX-2 pathway. Environ Health Perspect. 2014;122(3):255-261.
• Wei T, Jia J, Wada Y, et al. Dose dependent effects of cadmium on tumor angiogenesis. Oncotarget. 2017;8(27):44944-44959.
• Tsoi MF, Lo CWH, Cheung TT, et al. Blood lead level and risk of hypertension in the United States National Health And Nutrition Examination Survey 1999–2016. Sci Rep. 2021;11(1):3010.
• Lamas GA, Bhatnagar A, Jones MR, et al. Contaminant metals as cardiovascular risk factors: a scientific statement from the American Heart Association. J Am Heart Assoc. 2023;12(13):e029852.
• Turksoy VA, Yalvac ES, Simsek OT, et al. Impact of zinc on birth and placental weight in cadmium and lead exposure during pregnancy. Indian J Forensic Med Pathol. 2019; 12(3):246-254.
• Paithankar JG, Saini S, Dwivedi S, et al. Heavy metal associated health hazards: an interplay of oxidative stress and signal transduction. Chemosphere. 2021;262:128350.
• Sevim Ç, Doğan E, Comakli S. Cardiovascular disease and toxic metals. Curr Opin Toxicol. 2020;19:88-92.
• Dugani S, Gaziano TA. 25 by 25: achieving global reduction in cardiovascular mortality. Curr Cardiol Rep. 2016;18(1):10.
• Solenkova NV, Newman JD, Berger JS, Thurston G, Hochman JS, Lamas GA. Metal pollutants and cardiovascular disease: mechanisms and consequences of exposure. Am Heart J. 2014;168(6):812-822.
• Yerli C, Cakmakcı T, Sahin U, et al. The Effects of heavy metals on soil, plant, water and human health. Turkish J Nat Sci. 2020;9:103-114.
• Aschner M, Erikson KM, Hernández EH, et al. Manganese and its role in Parkinson’s disease: from transport to neuropathology. Neuromolecular Med. 2009;11(4):252-266.
• Turksoy VA, Tutkun L, Gunduzoz M, et al. Changing levels of selenium and zinc in cadmium-exposed workers: probable association with the intensity of inflammation. Mol Biol Rep. 2019;46(5):5455-5464.
• Begum F, Me HM, Christov M. The role of zinc in cardiovascular disease. Cardiol Rev. 2022;30(2):100-108.
• Shin MY, Kwun IS. Zinc restored the decreased vascular smooth muscle cell viability under atherosclerotic calcification conditions. Prev Nutr Food Sci. 2014;19(4):363-366.
• Voelkl J, Tuffaha R, Luong TTD, et al. Zinc ınhibits phosphate-ınduced vascular calcification through TNFAIP3-mediated suppression of NF- κ B. J Am Soc Nephrol. 2018;29(6):1636-1648.
• Chen W, Eisenberg R, Mowrey WB, et al. Association between dietary zinc intake and abdominal aortic calcification in US adults. Nephrol Dial Transplant. 2020;35(7):1171-1178.
• Houston MC. Role of mercury toxicity in hypertension, cardiovascular disease, and stroke. J Clin Hypertens (Greenwich). 2011;13(8):621-627.
• Hu XF, Lowe M, Chan HM. Mercury exposure, cardiovascular disease, and mortality: a systematic review and dose-response meta-analysis. Environ Res. 2021;193:110538.
• Lin CH, Hsu YT, Yen CC, et al. Association between heavy metal levels and acute ischemic stroke. J Biomed Sci. 2018;25(1):49.
• Ikediobi CO, Badisa VL, Ayuk-Takem LT, et al. Response of antioxidant enzymes and redox metabolites to cadmium-induced oxidative stress in CRL-1439 normal rat liver cells. Int J Mol Med. 2004;14(1):87-92.
• Prozialeck WC, Edwards JR, Woods JM. The vascular endothelium as a target of cadmium toxicity. Life Sci. 2006;79(16):1493-1506.
• Kishimoto T, Ueda D, Isobe M, et al. Cadmium injures tube formation by cultured human vascular endothelial cells. Hum Cell. 1996;9(3):244-250.
• Harlan WR. The relationship of blood lead levels to blood pressure in the U.S. population. Environ Health Perspect. 1988;78:9-13.
• Nunes FL da S, Lima SCVC, Lyra C de O, et al. The impact of essential and toxic elements on cardiometabolic risk factors in adults and older people. J Trace Elem Med Biol. 2022;72:126991.
• Miller M, Stone NJ, Ballantyne C, et al. Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2011;123(20):2292-2333.
• Liu Y, Geng T, Wan Z, et al. Associations of serum folate and vitamin B12 levels with cardiovascular disease mortality among patients with type 2 diabetes. JAMA Netw Open. 2022;5(1):e2146124.
• Li Y, Huang T, Zheng Y, et al. Folic acid supplementation and the risk of cardiovascular diseases: a meta-analysis of randomized controlled trials. J Am Heart Assoc. 2016;5(8):e003768.
• Møller L, Kristensen TS. Blood lead as a cardiovascular risk factor. Am J Epidemiol. 1992;136(9):1091-1100.
• Kim JH, Byun HM, Chung EC, et al. Loss of ıntegrity: ımpairment of the blood-brain barrier in heavy metal-associated ıschemic stroke. Toxicol Res. 2013;29(3):157-164.
• Mitra J, Vasquez V, Hegde PM, et al. Revisiting metal toxicity in neurodegenerative diseases and stroke: therapeutic potential. Neurol Res Ther. 2014;1(2):107. doi:10.14437/NRTOA-1-107
• Prozialeck WC, Edwards JR, Nebert DW, et al. The vascular system as a target of metal toxicity. Toxicol Sci. 2008;102(2):207-218.
• Kaji T. Cell biology of heavy metal toxicity in vascular tissue. J Pharm Soc Japan. 2004;124(3):113-120.